Xenetic (XBIO) insider files Schedule 13G reporting 5.5% stake
Xenetic Biosciences, Inc. Schedule 13G reports beneficial ownership by MJL Manager LLC and Michael Liu.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Xenetic Biosciences, Inc. Schedule 13G reports beneficial ownership by MJL Manager LLC and Michael Liu. MJL Manager LLC holds 93,565 shares (reported as 4.1% of the class) and Michael Liu holds 126,741 shares (5.5%), with shared voting and dispositive power reported.
The filing states Michael Liu is sole control person of MJL and both reporting persons disclaim beneficial ownership of each other’s shares except for their pecuniary interest; signatures are dated 05/29/2026.
Key Figures
Key Terms
Schedule 13G regulatory
beneficial ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake does Michael Liu report in XBIO?
Does Michael Liu control MJL Manager LLC according to the filing?
What voting and dispositive powers are reported for XBIO holdings?
AI-generated analysis. How Rhea-AI works. Not financial advice.